Clinical Trials
4 trialsNCT04065269 2026-02-20
ATARI
Institute of Cancer Research, United Kingdom
Phase 2 Active not recruiting
NCT04483544 2025-04-29
Pembrolizumab and Olaparib in Cervical Cancer Patients
Baptist Health South Florida
Phase 2 Terminated
NCT04487587 2025-02-26
COMICE
The Clatterbridge Cancer Centre NHS Foundation Trust
Phase 2 Active not recruiting
NCT04641728 2022-08-09
Pembrolizumab Plus Olaparib in Patients With Recurrent Cervical Cancer
Saitama Medical University International Medical Center
Phase 2 Unknown